Obstructive sleep apnea is linked to an increased risk of long-term COVID. According to one study, persons with both sleep disturbance and COVID may benefit from clinical monitoring.
A medication in development for obstructive sleep apnoea (OSA) showed promising results after being tested in humans for the first time by Flinders University researchers.